1. Understanding of dopamine receptor structure as related to ligand interaction and mechanisms of drug signaling (e.g., functional selectivity).
2. Discovery/design of novel therapeutics.
3. Real (and false) mechanisms relating to xenobiotic perturbation of the CNS.